These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20551915)

  • 1. Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors.
    Su X; Kells AP; Salegio EA; Salegio EA; Richardson RM; Hadaczek P; Beyer J; Bringas J; Pivirotto P; Forsayeth J; Bankiewicz KS
    Mol Ther; 2010 Aug; 18(8):1490-5. PubMed ID: 20551915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery.
    Richardson RM; Gimenez F; Salegio EA; Su X; Bringas J; Berger MS; Bankiewicz KS
    Neurosurgery; 2011 Jul; 69(1):154-63; discussion 163. PubMed ID: 21430597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided convection-enhanced delivery of GDNF protein into monkey putamen.
    Gimenez F; Krauze MT; Valles F; Hadaczek P; Bringas J; Sharma N; Forsayeth J; Bankiewicz KS
    Neuroimage; 2011 Jan; 54 Suppl 1():S189-95. PubMed ID: 20080195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.
    Rocco MT; Akhter AS; Ehrlich DJ; Scott GC; Lungu C; Munjal V; Aquino A; Lonser RR; Fiandaca MS; Hallett M; Heiss JD; Bankiewicz KS
    Mol Ther; 2022 Dec; 30(12):3632-3638. PubMed ID: 35957524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease.
    Richardson RM; Kells AP; Rosenbluth KH; Salegio EA; Fiandaca MS; Larson PS; Starr PA; Martin AJ; Lonser RR; Federoff HJ; Forsayeth JR; Bankiewicz KS
    Mol Ther; 2011 Jun; 19(6):1048-57. PubMed ID: 21343917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain.
    Hadaczek P; Kohutnicka M; Krauze MT; Bringas J; Pivirotto P; Cunningham J; Bankiewicz K
    Hum Gene Ther; 2006 Mar; 17(3):291-302. PubMed ID: 16544978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain.
    Fiandaca MS; Varenika V; Eberling J; McKnight T; Bringas J; Pivirotto P; Beyer J; Hadaczek P; Bowers W; Park J; Federoff H; Forsayeth J; Bankiewicz KS
    Neuroimage; 2009 Aug; 47 Suppl 2(Suppl 2):T27-35. PubMed ID: 19095069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.
    Cunningham J; Pivirotto P; Bringas J; Suzuki B; Vijay S; Sanftner L; Kitamura M; Chan C; Bankiewicz KS
    Mol Ther; 2008 Jul; 16(7):1267-75. PubMed ID: 18523450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys.
    Johnston LC; Eberling J; Pivirotto P; Hadaczek P; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 May; 20(5):497-510. PubMed ID: 19203243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.
    Sanftner LM; Sommer JM; Suzuki BM; Smith PH; Vijay S; Vargas JA; Forsayeth JR; Cunningham J; Bankiewicz KS; Kao H; Bernal J; Pierce GF; Johnson KW
    Exp Neurol; 2005 Aug; 194(2):476-83. PubMed ID: 16022872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics.
    Yin D; Richardson RM; Fiandaca MS; Bringas J; Forsayeth J; Berger MS; Bankiewicz KS
    J Neurosurg; 2010 Aug; 113(2):240-8. PubMed ID: 20367078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    Ciesielska A; Samaranch L; San Sebastian W; Dickson DW; Goldman S; Forsayeth J; Bankiewicz KS
    PLoS One; 2017; 12(2):e0169965. PubMed ID: 28166239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates.
    Nagahara AH; Wilson BR; Ivasyk I; Kovacs I; Rawalji S; Bringas JR; Pivirotto PJ; Sebastian WS; Samaranch L; Bankiewicz KS; Tuszynski MH
    Gene Ther; 2018 Apr; 25(2):104-114. PubMed ID: 29535375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery.
    Varenika V; Dickinson P; Bringas J; LeCouteur R; Higgins R; Park J; Fiandaca M; Berger M; Sampson J; Bankiewicz K
    J Neurosurg; 2008 Nov; 109(5):874-80. PubMed ID: 18976077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons.
    Pearson TS; Gupta N; San Sebastian W; Imamura-Ching J; Viehoever A; Grijalvo-Perez A; Fay AJ; Seth N; Lundy SM; Seo Y; Pampaloni M; Hyland K; Smith E; de Oliveira Barbosa G; Heathcock JC; Minnema A; Lonser R; Elder JB; Leonard J; Larson P; Bankiewicz KS
    Nat Commun; 2021 Jul; 12(1):4251. PubMed ID: 34253733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
    Ciesielska A; Sharma N; Beyer J; Forsayeth J; Bankiewicz K
    PLoS One; 2015; 10(4):e0122708. PubMed ID: 25860990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomic compression caused by high-volume convection-enhanced delivery to the brain.
    Valles F; Fiandaca MS; Bringas J; Dickinson P; LeCouteur R; Higgins R; Berger M; Forsayeth J; Bankiewicz KS
    Neurosurgery; 2009 Sep; 65(3):579-85; discussion 585-6. PubMed ID: 19687704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.
    Su X; Kells AP; Huang EJ; Lee HS; Hadaczek P; Beyer J; Bringas J; Pivirotto P; Penticuff J; Eberling J; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 Dec; 20(12):1627-40. PubMed ID: 19671001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates.
    Yin D; Valles FE; Fiandaca MS; Bringas J; Gimenez F; Berger MS; Forsayeth J; Bankiewicz KS
    Neuroimage; 2011 Jan; 54 Suppl 1():S196-203. PubMed ID: 19761848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convection-enhanced delivery of M13 bacteriophage to the brain.
    Ksendzovsky A; Walbridge S; Saunders RC; Asthagiri AR; Heiss JD; Lonser RR
    J Neurosurg; 2012 Aug; 117(2):197-203. PubMed ID: 22606981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.